Skip to main content
. 2021 Sep 3;28(1):e100267. doi: 10.1136/bmjhci-2020-100267

Table 5.

Performance of models applied with deviations

Study Validation performance—reported from study Validation performance—NYU data Performance difference between study validation performance and NYU original validation performance Validation performance—NYU retrained (95% CI) Performance difference between study validation performance and NYU retrained validation performance NYU deviations from original
Gong et al5 Cohort 1: AUROC=0.85 AUROC=0.59 AUROC difference=0.26 AUROC=0.68
(0.64 to 0.74)
AUROC difference=0.17 PaO2 data not available. Target excluded
Gong et al5 Cohort 2: AUROC=0.75 AUROC=0.60 AUROC difference=0.16 AUROC=0.68
(0.64 to 0.74)
AUROC difference=0.07 PaO2 data not available. Target excluded
Zhou et al8 AUROC=0.88 AUROC=0.74 AUROC difference=0.14 AUROC=0.75
(0.71 to 0.78)
AUROC difference=0.14 ‘Severe respiratory distress’ target not characterisable. Target excluded
Zou et al9 * AUROC=0.70 * AUROC=0.72 (0.67 to 0.77) * Altered mental status measured as Glasgow Coma Score <15
Mean AUROC=0.83 Mean AUROC=0.66 Mean AUROC difference=0.19 Mean AUROC=0.71 Mean AUROC difference=0.13

*Value unavailable because authors did not provide an AUROC value when reporting validation performance.

AUROC, area under the receiver–operator curve; NYU, New York University; PaO2, partial pressure of oxygen.